1-5 of 5
Donald Berry
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Personalized Medicine for Patients with Advanced Cancer in the Phase I Program at MD Anderson: Validation and Landmark Analyses

Apostolia-Maria Tsimberidou, Sijin Wen, David S. Hong, Jennifer J. Wheler, Gerald S. Falchook, Siqing Fu, Sarina Piha-Paul, Aung Naing, Filip Janku, Kenneth Aldape, Yang Ye, Razelle Kurzrock, Donald Berry
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (18): 4827–4836.
https://doi.org/10.1158/1078-0432.CCR-14-0603
Published: 14 September 2014
View article titled, Personalized Medicine for Patients with Advanced Cancer in the Phase I Program at MD Anderson: Validation and Landmark Analyses
Open the PDF for Personalized Medicine for Patients with Advanced Cancer in the Phase I Program at MD Anderson: Validation and Landmark Analyses in another window
Includes: Supplementary data
Journal Articles

Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative

Apostolia-Maria Tsimberidou, Nancy G. Iskander, David S. Hong, Jennifer J. Wheler, Gerald S. Falchook, Siqing Fu, Sarina Piha-Paul, Aung Naing, Filip Janku, Rajyalakshmi Luthra, Yang Ye, Sijin Wen, Donald Berry, Razelle Kurzrock
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (22): 6373–6383.
https://doi.org/10.1158/1078-0432.CCR-12-1627
Published: 14 November 2012
View article titled, Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative
Open the PDF for Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative in another window
Includes: Supplementary data
Journal Articles

The Design of Phase II Clinical Trials Testing Cancer Therapeutics: Consensus Recommendations from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee

Lesley Seymour, S. Percy Ivy, Daniel Sargent, David Spriggs, Laurence Baker, Larry Rubinstein, Mark J. Ratain, Michael Le Blanc, David Stewart, John Crowley, Susan Groshen, Jeffrey S. Humphrey, Pamela West, Donald Berry
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (6): 1764–1769.
https://doi.org/10.1158/1078-0432.CCR-09-3287
Published: 14 March 2010
View article titled, The Design of Phase II Clinical Trials Testing Cancer Therapeutics: Consensus Recommendations from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee
Open the PDF for The Design of Phase II Clinical Trials Testing Cancer Therapeutics: Consensus Recommendations from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee in another window
Journal Articles

Evaluation of Paclitaxel in Adjuvant Chemotherapy for Patients with Operable Breast Cancer: Preliminary Data of a Prospective Randomized Trial

Aman U. Buzdar, S. Eva Singletary, Vicente Valero, Daniel J. Booser, Nuhad K. Ibrahim, Zia Rahman, Richard L. Theriault, Ronald Walters, Edgardo Rivera, Terry L. Smith, Frankie A. Holmes, Emma Hoy, Debra K. Frye, Nikki Manuel, Shu-Wan Kau, Marsha D. McNeese, Eric Strom, Eva Thomas, Kelly Hunt, Fred Ames, Donald Berry, Gabriel N. Hortobagyi
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (5): 1073–1079.
Published: 01 May 2002
View article titled, Evaluation of Paclitaxel in Adjuvant Chemotherapy for Patients with Operable Breast Cancer: <subtitle>Preliminary Data of a Prospective Randomized Trial</subtitle>
Open the PDF for Evaluation of Paclitaxel in Adjuvant Chemotherapy for Patients with Operable Breast Cancer: <subtitle>Preliminary Data of a Prospective Randomized Trial</subtitle> in another window
Journal Articles

Association of High-dose Cyclophosphamide, Cisplatin, and Carmustine Pharmacokinetics with Survival, Toxicity, and Dosing Weight in Patients with Primary Breast Cancer

William P. Petros, Gloria Broadwater, Donald Berry, Roy B. Jones, James J. Vredenburgh, Colleen J. Gilbert, John P. Gibbs, O. Michael Colvin, William P. Peters
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (3): 698–705.
Published: 01 March 2002
View article titled, Association of High-dose Cyclophosphamide, Cisplatin, and Carmustine Pharmacokinetics with Survival, Toxicity, and Dosing Weight in Patients with Primary Breast Cancer
Open the PDF for Association of High-dose Cyclophosphamide, Cisplatin, and Carmustine Pharmacokinetics with Survival, Toxicity, and Dosing Weight in Patients with Primary Breast Cancer in another window